Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 3, 2005, Pages 357-363

  Staffen, Wolfgang ^a   Zauner, Harald ^b   Mair, Aldis ^b   Kutzelnigg, Andrea ^b   Kapeller, Peter ^b   Stangl, Hilde ^b   Raffer, Edith ^b   Niederhofer, Helmut ^b   Ladurner, Gunther ^b  

^a Christian Doppler Klinik   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID; ASPARTIC ACID; CHOLINE; CREATINE PHOSPHATE; PROTON;

ADULT; ARTICLE; BRAIN REGION; CELL VIABILITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN; MEMORY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; SCORING SYSTEM; WECHSLER MEMORY SCALE; ADOLESCENT; COMPARATIVE STUDY; DISABILITY; FEMALE; FRONTAL LOBE; MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS;

ADOLESCENT; ADULT; ASPARTIC ACID; CHOLINE; DISABILITY EVALUATION; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PHOSPHOCREATINE; PROTONS; STATISTICS, NONPARAMETRIC;

EID: 85047697314     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.3.357     Document Type: Article

References (54)

1. Farlow MR, Marhand ON, Edwards MK, et al: Multiple sclerosis: magnetic resonance imaging, evoked responses and spinal fluid electrophoresis. Neurol 1986; 36:828-831
2. Paty DW, Oger JJF, Kastrukoff LF, et al: MR in the diagnosis of MS: a prespective study with comparision of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurol 1988; 38:180-185
3. Staffen W, Trinka E, Ladurner G: Contribution of MRI, multi-modal evoked potentials and CSF changes to the diagnosis of multiple sclerosis. Nervenarzt 1993; 64:226-232
4. Rao SM, Hammeke TA, Mc Quillen MP, et al: Memory disturbances in chronic progressive multiple sclerosis. Arch Neurol 1984; 41:625-631
5. Rao SM: Neuropsychology of multiple sclerosis: A critical review. J Clin Exp Neuropsychol 1986; 8:503-542
6. Van den Burg W, van Zomeren AH, Minderhaud JM, et al: Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol 1987; 44:494-501
7. Rao SM, Leo GJ, Unverzagt F: Cognitive dysfunction in multiple sclerosis: frequency, patterns predictions. Neurology 1991; 41:2014-2015
8. Gilchrist AC, Creed FH: Depression, cognitive impairment and social stress in multiple sclerosis. J Psychosom Res 1994; 38:193-201
9. Amato MP, Ponzaini G, Pracucci G, et al: Cognitive impairment in early onset multiple sclerosis: pattern, predictors, and impact on everyday life in a four year follow up. Arch Neurol 1995; 52:168-172
10. Thornton AE, Raz N: Memory impairment in multiple sclerosis: a quantitative review. Neuropsychol 1997; 11:357-366
11. Gaudino EA, Chiaravalloti ND, DeLuca J, et al: A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:32-44
12. Rao SM, Leo GJ, Haughton VM, et al: Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39:161-166
13. Breteler MB, van Amerongen NM, van Swieten JC, et al: Cognitive correlates of ventricular enlargement and cerebral white matter lesions and magnetic resonance imaging. The rotterdam study. Stroke 1994; 25:1109-1115
14. Comi G, Filippi M, Martinelli V, et al: Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple slerosis. J Neuro Sci 1995; 132:222-227
15. Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15:289-298
16. Urenjak J, Willliams SR, Gadian DG, et al: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989
17. De Stefano N, Matthews PM, Narayanan S, et al: Axonal dysfunction and disability in a relaps of multiple sclerosis: a longitudinal study of a patient. Neurol 1997; 49:1138-1141
18. De Stefano N, Matthews PM, Fu L, et al: Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis, results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121:1469-1477
19. Arnold DL, Wolinky JS, Matthews PM, et al: The use of magnetic resonance spectroscopy in the evaluation of natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64:S94-S101
20. Brex PA, Gomez-Anson B, Parker GJ, et al: Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 1999; 166:16-22
21. Matthews PM, De Stefano N, Narayanan S, et al: Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998; 18:327-336
22. Davie DA, Silver NC, Barker GJ, et al: Does extent of axonal loss and demyelinisation from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neuro Neurosurg Psychiatry 1999; 67:710-715
23. Lee MA, Blamire AM, Pendlebury S, et al: Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol 2000; 57:65-70
24. Fletcher PC, Henson RNA: Frontal lobes and human memory, insights from functional neuroimaging. Brain 2001; 124:849-881
25. Fazio F, Perani D, Gilardi MC, et al: Metabolic impairment in human amnesia: a PET study of memory networks. J Cereb Blood Flow and Metab 1992; 12:353-358
26. Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior congulate cortex to behaviour. Brain 1995; 118:279-306
27. Cabeza R, Nyberg L: Imaging cognition II: An empirical review of 275 PET and FMRI studies. J Cogn Neurosci 2000; 12:1-47
28. Poser CM, Paty DW, Scheinberger LC, et al: New diagnosis criteria for MS: guidelines for research protocols. Ann Neurol 1983; 13:227
29. Kurtzke J: Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33:1444-1452
30. Wechsler D: A standardised memory scale for clinical use. J Psychol 1945; 87-95
31. Fischer JS, Rudick RA, Cutter GR, et al: The Multiple Sclerosis Functional Composite (MSFC) measure: an integrated approach to MS clinical outcome measurement. Multiple Sclerosis 1999; 5:244-250
32. Talairach J, Tournoux P: Co-planar stereotaxic atlas of the human brain: Three dimensional proportional system. An approach to cerebral imaging. Thieme, Stuttgart: New York 1988
33. Miller BL: A review of chemical issues in 1-H-NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4:47-52
34. Miller DH, Grossman RI, Reingold SC, et al: The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121:3-24
35. Barkhof F, van Waldeveen MA: Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 1999; 354:1675-1686
36. Simone IL, Tortorella C, Federico F: The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. Ital J Neurol Sci 1999; 20: 5 Suppl 241-245
37. van Walderveen MA, Barkhof F, Pouwels PJ, et al: Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999; 46: 179-87
38. Fu L, Wolfson C, Worsley KJ, et al: Statistics of investigation of multimodal MR imaging data and an application to multiple sclerosis patients. NMR Biomed 1996; 9:339-346
39. Fu L, Matthews N, De Stefano N, et al: Imaging normal-appearing white matter in multiple sclerosis. Brain 1998; 121:103-113
40. Davie CA, Barker GJ, Thompson AJ, et al: 1H magnetic resonance spectroscopy of chronic white matter lesions in normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63:736-742
41. Clanet M, Berry I: Magnetic resonance imaging in multiple sclerosis. Curr Opin Neurol 1998; 11:299-303
42. Sarchielli P, Presciutti O, Tarducci R, et al: 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. J Neurol Neurosurg Psychiatry 1998; 64:204-212
43. Sarchielli P, Presciutti O, Pelliccioli GP, et al: Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal appearing white matter of multiple sclerosis patients. Brain 1999; 122:513-521
44. Leary SM, Davie CA, Parker GJ, et al: 1H magnetic resonance spectroscopy of normal apearing white matter in primary progressive multiple sclerosis. J Neurol 1999; 11:1023-1026
45. Tourbah A, Stievenart JL, Gout O, et al: Localized magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. Neurology 1999; 53:1091-1097
46. Foong J, Rozewicz L, Davie CA, et al: Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J Neurosci Clin Neurosci 1999; 11:45-50
47. Jung RE, Yeo RA, Chiulli SJ, et al: Biochemical markers of cognition: a proton MR spectroscopy of normal human brain. Neuroreport 1999; 10:3327-3331
48. Pan JW, Krupp LB, Elkins LE, Coyle PK: Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Appl Neuropsychol 2001; 8:155-160
49. Kapeller P, McLean, Griffin CM, et al: Peliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopy imaging study. J Neurol 2001; 248:131-138
50. Sharma R, Narayana PA, Wolinsky JS: Gray matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 2001; 7:221-226
51. McClean MA et al: Metabolite content in cerebral grey and white matter studied with short-echo time 1H-MRSI. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000, Denver, CO, p 1131
52. Persciutti O, Sarchielli P, Gobbi G: 1H MRS study of occipital grey matter of multiple sclerosis patients. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000, Denver, CO, p 627
53. Bush G, Luu P, Posner MI: Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4:215-222
54. Duncan J, Owen AM: Common regions of the human frotal lobe recruited by diverse cognitive demands. Trends Neurosci 2000; 23:475-483